Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 2296-5262|35|6|335-340

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.6, 2012-05, pp. : 335-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinal Abnormalities in Newly Diagnosed Adult Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 197-203

Karger

Access to resources Recommend Favorite

Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis

By  

Acta Haematologica, Vol. 138, Iss. 2, 2017-09 ,pp. : 116-118

Karger

Access to resources Recommend Favorite

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 639-646

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4162-4169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 213-221

John Wiley & Sons Inc

Access to resources Recommend Favorite